Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127275521 | 12727552 | 1 | I | 201604 | 20160822 | 20160909 | 20160909 | PER | US-ELI_LILLY_AND_COMPANY-US201608011476 | ELI LILLY AND CO | 71.01 | YR | M | Y | 0.00000 | 20160909 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127275521 | 12727552 | 1 | PS | CIALIS | TADALAFIL | 1 | Unknown | 20 MG, 1-3 TIMES PER MONTH | U | U | 21368 | 20 | MG | TABLET | |||||
| 127275521 | 12727552 | 2 | C | LOSARTAN. | LOSARTAN | 1 | 0 | ||||||||||||
| 127275521 | 12727552 | 3 | C | HCTZ | HYDROCHLOROTHIAZIDE | 1 | 0 | ||||||||||||
| 127275521 | 12727552 | 4 | C | ATORVASTATIN | ATORVASTATIN | 1 | 0 | ||||||||||||
| 127275521 | 12727552 | 5 | C | ABTEI VITAMIN D3 | 2 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127275521 | 12727552 | 1 | Erectile dysfunction |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127275521 | 12727552 | Blood testosterone decreased | |
| 127275521 | 12727552 | Drug effect decreased | |
| 127275521 | 12727552 | Flushing |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127275521 | 12727552 | 1 | 2014 | 0 |